Thyroglobulin-positive, radioiodine-negative thyroid cancer

被引：6
|
作者：
Levy, EG [1 ]
机构：
[1] Univ Miami, Sch Med, Miami, FL 33152 USA
来源：
THYROID | 2001年 / 11卷 / 06期
关键词：
D O I：
10.1089/105072501750302921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：599 / 602
页数：4
相关论文
共 50 条
  • [31] Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody
    Choi S.J.
    Jung K.P.
    Lee S.S.
    Park Y.S.
    Lee S.M.
    Bae S.K.
    [J]. Nuclear Medicine and Molecular Imaging, 2016, 50 (2) : 130 - 136
  • [32] Relationship between clinicopathologic factors and FDG avidity in radioiodine-negative recurrent or metastatic differentiated thyroid carcinoma
    Le Ngoc Ha
    Amir Iravani
    Nguyen Thi Nhung
    Ngo Thi Minh Hanh
    Febby Hutomo
    Mai Hong Son
    [J]. Cancer Imaging, 21
  • [33] Does ultrasound-guided fine needle aspiration have an additional value to FDG PET in detection of radioiodine-negative metastatic thyroid cancer?
    Nakada, K
    Takei, T
    Kaji, T
    Hirata, K
    Katoh, C
    Kuge, Y
    Tsukamoto, E
    Tamaki, N
    Yamashita, H
    Noguchi, S
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05): : 333P - 333P
  • [34] FDG PET scan in the follow-up of differentiated thyroid cancer: Contribution for patients with positive serum thyroglobulin levels and negative therapeutic radioiodine scans.
    Helal, BO
    Merlet, P
    Toubert, ME
    Daou, D
    Saidi, L
    Maziere, B
    Syrota, A
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05): : 102P - 102P
  • [35] Experimental peptide receptor radionuclide therapy in radioiodine negative somatostatin receptor positive thyroid cancer
    Nilica, B.
    Kroiss, A.
    Putzer, D.
    Uprimny, C.
    Warwitz, B.
    Kendler, D.
    Waitz, D.
    Virgolini, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S125 - S125
  • [36] Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan
    Ansari, M.
    Babaei, A. A.
    Shafiei, B.
    Javadi, H.
    Assadi, M.
    Nabipour, I.
    Asli, I. N.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (13) : 1925 - 1929
  • [37] Thyroglobulin autoantibodies before radioiodine ablation predict differentiated thyroid cancer outcome
    Trimboli, Pierpaolo
    Zilioli, Valentina
    Imperiali, Mauro
    Giovanella, Luca
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (12) : 1995 - 2001
  • [38] Predictive value of preablation-stimulated thyroglobulin and Δthyroglobulin for the successful radioiodine ablation therapy of papillary thyroid cancer
    Jung, Kyung Pyo
    Lee, Ah Young
    Park, Ji Sun
    Lee, Seokmo
    Kim, Tae Hyoun
    Bae, Sang Kyun
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [39] Predictive value of preablation-stimulated thyroglobulin and Δthyroglobulin for the successful radioiodine ablation therapy of papillary thyroid cancer
    Jung, Kyung Pyo
    Lee, Ah Young
    Park, Ji Sun
    Lee, Seokmo
    Kim, Tae Hyoun
    Bae, Sang Kyun
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [40] Thyroglobulin positive, RAI negative thyroid cancers: The role of conservative management
    Sherman, SI
    Gopal, J
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (12): : 4199 - 4200
12345